Cargando…
Development of circulating tumour DNA analysis for gastrointestinal cancers
Comprehensive genomic profiling using next-generation sequencing (NGS) enables the identification of multiple genomic biomarkers established in advanced gastrointestinal (GI) cancers. However, tissue-based NGS has limitations, such as long turnaround time and failure to detect tumour heterogeneity....
Autores principales: | Nakamura, Yoshiaki, Shitara, Kohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003376/ https://www.ncbi.nlm.nih.gov/pubmed/32830648 http://dx.doi.org/10.1136/esmoopen-2019-000600 |
Ejemplares similares
-
Circulating tumour cells in gastrointestinal cancers: food for thought?
por: Asawa, Simran, et al.
Publicado: (2023) -
DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008) -
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not?
por: Pretta, Andrea, et al.
Publicado: (2022) -
Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015) -
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)